DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Halcion (Triazolam) - Published Studies

 
 



Halcion Related Published Studies

Well-designed clinical trials related to Halcion (Triazolam)

Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women. [2011.06]

Dose effects of triazolam and scopolamine on metamemory. [2010.02]

Flumazenil reversal of sublingual triazolam: a randomized controlled clinical trial. [2009.05]

Modulation of the discriminative stimulus effects of triazolam across the menstrual cycle phase in healthy pre-menopausal women. [2008.04.01]

Relative abuse liability of GHB in humans: A comparison of psychomotor, subjective, and cognitive effects of supratherapeutic doses of triazolam, pentobarbital, and GHB. [2006.11]

Dose effects of triazolam on brain activity during episodic memory encoding: a PET study. [2006.11]

Decreasing pain and anxiety associated with patient-activated atrial shock: a placebo-controlled study of adjunctive sedation with oral triazolam. [2006.04]

Effect of benzodiazepine hypnotic triazolam on relationship of blood pressure and Paco2 to cerebral blood flow during human non-rapid eye movement sleep. [2006.04]

Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam. [2006.03]

An abuse liability comparison of flunitrazepam and triazolam in sedative drug abusers. [2005.11]

Pharmocokinetics and pharmacodynamics of single-dose triazolam: electroencephalography compared with the Digit-Symbol Substitution Test. [2005.09]

Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement. [2005.08]

Temporal changes in postural sway caused by ultrashort-acting hypnotics: triazolam and zolpidem. [2005]

Well-designed clinical trials possibly related to Halcion (Triazolam)

Anti-anxiety drugs reduce conflict-specific "theta"--a possible human anxiety-specific biomarker. [2013]

Pharmacological treatment of insomnia in alcohol recovery: a systematic review. [2011.09]

Effect of hypnotic drugs on body balance and standing steadiness. [2010]

Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice. [2007.03]

Effect of extended exposure to grapefruit juice on cytochrome P450 3A activity in humans: comparison with ritonavir. [2006.03]

Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. [2006.01]

Zaleplon (Sonata) oral sedation for outpatient third molar extraction surgery. [2005.01]

Other research related to Halcion (Triazolam)

Anticonflict and reinforcing effects of triazolam + pregnanolone combinations in rhesus monkeys. [2011.06]

[Comprehensive evaluation of the effect of triazolam on amnesia during the preoperative period]. [2011.01]

Pharmacokinetic modeling of the dosing interval dependency for the interaction between itraconazole and triazolam. [2010.06]

Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans. [2010.03]

Determination of triazolam and alpha-hydroxytriazolam in guinea pig hair after a single dose. [2010.03]

A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine. [2010.02]

Dose effects of triazolam and alcohol on cognitive performance in healthy volunteers. [2010.02]

The reinforcing, self-reported performance and physiological effects of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in cannabis users. [2010.02]

Determination of triazolam and alpha-hydroxytriazolam in guinea pig hair after a single dose. [2010]

Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam. [2009.12]

Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings. [2009.11.03]

Expanded studies of the pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers. [2009.10]

Cognitive, psychomotor, and subjective effects of sodium oxybate and triazolam in healthy volunteers. [2009.09]

Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol. [2009.04]

Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. [2009.03]

Acute intoxication by triazolam and promazine: a case report. [2009.01]

Effect of sublingual triazolam on the success of inferior alveolar nerve block in patients with irreversible pulpitis. [2008.10]

Relative abuse liability of indiplon and triazolam in humans: a comparison of psychomotor, subjective, and cognitive effects. [2007.08]

A triazolam/amphetamine dose-effect interaction study: dissociation of effects on memory versus arousal. [2007.06]

Pharmacokinetics and clinical effects of multidose sublingual triazolam in healthy volunteers. [2006.02]

Discriminative-stimulus effects of triazolam in women and men. [2006]

Comparison of the behavioral effects of bretazenil and flumazenil in triazolam-dependent and non-dependent baboons. [2005.09.05]

Criminal injury case using vegetable juice intermixed with triazolam. [2005.08]

Urinary excretion profiles of two major triazolam metabolites, alpha-hydroxytriazolam and 4-hydroxytriazolam. [2005.05]

Hallucinations and delirium in the dental office following triazolam administration. [2005.03]

Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans. [2005.02]

Other possibly related research studies

Practical oral sedation in dentistry. Part II--Clinical application of various oral sedatives and discussion. [2006.09]

Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects. [2006.10]

Potentiation of ethanol in spatial memory deficits induced by some benzodiazepines. [2006.08]

Balancing efficacy and safety in the use of oral sedation in dental outpatients. [2006.04]

Calculating and justifying total anxiolytic doses of medications for in-office use. [2006.01]

The use of anxiolytic medications to supplement local anesthesia in the anxious patient. [2005.03]

Combined discriminative stimulus effects of midazolam with other positive GABAA modulators and GABAA receptor agonists in rhesus monkeys. [2005.04]

A fatal poisoning caused by methomyl and nicotine. [2005.05.10]

Drug use and HIV/AIDS in China. [2006.03]

Quetiapine for insomnia associated with refractory depression exacerbated by phenelzine. [2006.03]

Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. [2005]

Benefit-risk assessment of zaleplon in the treatment of insomnia. [2005]

Maximum cumulative doses of sedation medications for in-office use. [2007.03]

Adult oral sedation in California: what can a dentist do without a special permit or certificate from the Dental Board of California? [2006.12]

Effectiveness and safety of hypnotic drugs in the treatment of insomnia in over 70-year old people. [2007]

Enteral sedation: safety, efficacy, and controversy. [2007.05]

Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam. [2007.07.02]

Beating jet lag. [2007.06]

Pharmacological manipulations of arousal and memory for emotional material: effects of a single dose of methylphenidate or lorazepam. [2007.09]

Chronic ethanol intake modulates photic and non-photic circadian phase responses in the Syrian hamster. [2007.08]

Sustained inhibition of brotizolam induced anterograde amnesia by norharmane and retrograde amnesia by L-glutamic acid in mice. [2007.08.22]

Evidence of safety for individualized dosing of enteral sedation. [2007.09]

What every dentist should know about the "z-sedatives". [2007.09]

Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects. [2008]

Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation. [2008.03]

High prevalence of HCV in a cohort of injectors on methadone substitution treatment. [2008.04]

Evaluation of anxiolytic-like effects of some short-acting benzodiazepine hypnotics in mice. [2008.07]

Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. [2008.07]

Rebound insomnia induced by abrupt withdrawal of hypnotics in sleep-disturbed rats. [2008.11.12]

Estimating the efficiency of benzodiazepines on GABA(A) receptors comprising gamma1 or gamma2 subunits. [2008.10]

Antibiotics suppress Cyp3a in the mouse liver by reducing lithocholic acid-producing intestinal flora. [2009.05]

Quantitative relationship between rifampicin exposure and induction of Cyp3a11 in SXR humanized mice: extrapolation to human CYP3A4 induction potential. [2008.08]

Contribution of alpha1 subunit-containing gamma-aminobutyric acidA (GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys. [2009.04]

Best practice guide for the treatment of nightmare disorder in adults. [2010.08.15]

Drug interactions during periodontal therapy in HIV-infected subjects. [2010.07]

Differences in the pharmacokinetics of Cyp3a substrates in TSOD and streptozotocin-induced diabetic mice. [2010.04]

Does effective management of sleep disorders improve pain symptoms? [2009]

Use of bispectral index system (BIS) to Monitor Enteral Conscious (moderate) sedation during general dental procedures. [2009.12]

Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice. [2009.09]

Separate evaluation of intestinal and hepatic metabolism of three benzodiazepines in rats with cannulated portal and jugular veins: comparison with the profile in non-cannulated mice. [2009.11]

Assessment of algorithms for predicting drug-drug interactions via inhibition mechanisms: comparison of dynamic and static models. [2011.01]

Emergence of anti-conflict effects of zolpidem in rhesus monkeys following extended post-injection intervals. [2011.04]

Drug interactions during periodontal therapy in HIV-infected subjects. [2010.07]

Effect of ethanol on sleep-awake state in sleep-disturbed rats. [2010]

Effect of hypnotic drugs on body balance and standing steadiness. [2010.08]

Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates. [2010.01]

Efficacy and safety of neuromodulators in inflammatory arthritis: a Cochrane systematic review. [2012]

Muscle relaxants for pain management in rheumatoid arthritis. [2012]

Pharmacological treatment of insomnia in alcohol recovery: a systematic review. [2011]

Best practice guide for the treatment of nightmare disorder in adults. [2010]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017